These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children. Antzelevitch C J Electrocardiol; 2001; 34 Suppl():177-81. PubMed ID: 11781953 [TBL] [Abstract][Full Text] [Related]
4. Heart rhythm characterization during sudden cardiac death in dogs. Santilli R; Saponaro V; Carlucci L; Perego M; Battaia S; Borgarelli M J Vet Cardiol; 2021 Dec; 38():18-30. PubMed ID: 34710652 [TBL] [Abstract][Full Text] [Related]
5. Sudden cardiac death in Long QT syndrome (LQTS), Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT). Singh M; Morin DP; Link MS Prog Cardiovasc Dis; 2019; 62(3):227-234. PubMed ID: 31078562 [TBL] [Abstract][Full Text] [Related]
6. Catheter and Device Management of Inherited Cardiac Conditions. Bennett R; Campbell T; Kumar S Heart Lung Circ; 2020 Apr; 29(4):594-606. PubMed ID: 32014423 [TBL] [Abstract][Full Text] [Related]
7. Monogenec Arrhythmic Syndromes: From Molecular and Genetic Aspects to Bedside. E Z G; O I G; R A S; N I B; L A B Acta Naturae; 2016; 8(2):62-74. PubMed ID: 27437140 [TBL] [Abstract][Full Text] [Related]
8. ECG quantification of myocardial scar and risk stratification in MADIT-II. Loring Z; Zareba W; McNitt S; Strauss DG; Wagner GS; Daubert JP Ann Noninvasive Electrocardiol; 2013 Sep; 18(5):427-35. PubMed ID: 24047486 [TBL] [Abstract][Full Text] [Related]
9. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome. Antzelevitch C; Yan GX; Shimizu W J Electrocardiol; 1999; 32 Suppl():158-65. PubMed ID: 10688320 [TBL] [Abstract][Full Text] [Related]
10. Too long or too short? New insights into abnormal cardiac repolarization in people with chronic epilepsy and its potential role in sudden unexpected death. Surges R; Taggart P; Sander JW; Walker MC Epilepsia; 2010 May; 51(5):738-44. PubMed ID: 20384763 [TBL] [Abstract][Full Text] [Related]
11. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia. Roses-Noguer F; Jarman JW; Clague JR; Till J Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999 [TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy in inherited and acquired ventricular arrhythmia in structurally normal adult hearts. Ortmans S; Daval C; Aguilar M; Compagno P; Cadrin-Tourigny J; Dyrda K; Rivard L; Tadros R Expert Opin Pharmacother; 2019 Dec; 20(17):2101-2114. PubMed ID: 31566420 [No Abstract] [Full Text] [Related]
17. Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review. Hilleman DE; Bauman AL Pharmacotherapy; 2001 May; 21(5):556-75. PubMed ID: 11349745 [TBL] [Abstract][Full Text] [Related]
18. Management of arrhythmias in patients with Takotsubo cardiomyopathy: Is the implantation of permanent devices necessary? Stiermaier T; Rommel KP; Eitel C; Möller C; Graf T; Desch S; Thiele H; Eitel I Heart Rhythm; 2016 Oct; 13(10):1979-86. PubMed ID: 27298201 [TBL] [Abstract][Full Text] [Related]
20. Clinical characteristic and clinical course of aborted sudden cardiac death patients with structurally normal heart in King Chulalongkorn Memorial Hospital. Thamaree S; Sunsaneewitayakul B J Med Assoc Thai; 2013 Mar; 96(3):272-9. PubMed ID: 23539928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]